ERBB2 and breast carcinoma: To assess in vitro cytotoxicity, the two CARs were evaluated against three breast cancer cell lines with BT474 cells (high HER2 expression), HCC1954 cells (intermediateHER2 expression), and MCF-7 cells (low HER2 expression).